Company: PACB
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001299130-25-000102
Chunk: 191

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 191
---
 stock outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares of common stock outstanding and potential shares assuming the dilutive effect of the Notes, using the if-converted method, and outstanding equity awards using the treasury stock method.

Q1 Fiscal 2025 Form 10-Q26

The following table presents the calculation of the basic and diluted net loss per share amounts presented in the condensed consolidated statements of operations and comprehensive loss:Three Months Ended March 31,(In thousands, except per share amounts)20252024Numerator:Net loss$(426,075)$(78,178)Denominator:BasicWeighted average shares used in computingbasic net loss per share296,858269,578Basic net loss per share$(1.44)$(0.29)DilutedWeighted average shares used in computingdiluted net loss per share296,858269,578Diluted net loss per share$(1.44)$(0.29)The following shares issuable upon conversion of the Notes and outstanding equity awards were excluded from the computation of diluted net loss per share for the periods presented because the effect of including such shares would have been antidilutive:Three Months Ended March 31,(In thousands)20252024Shares issuable upon conversion of convertible senior notes61,41531,063Equity Awards47,13336,924See Note 7. Equity Plans and Share-Based Compensation for detailed information on equity awards.

NOTE 9.  SEGMENT AND GEOGRAPHIC INFORMATIONWe are organized as, and operate in, one reportable segment: the development, manufacturing, and marketing of integrated platforms for genetic analysis. Our chief operating decision-maker (CODM) is our Chief Executive Officer. Our CODM reviews financial information presented on a consolidated basis for the purposes of evaluating financial performance and allocating resources.On a regular basis, our CODM reviews:•total revenues by category•total expenses and expenses by function, including sales and marketing and general and administrative, which include depreciation and share-based compensation•net loss per shareOur assets are primarily located in the United States of America and not allocated to any specific region, and we do not measure the performance of geographic regions based upon asset-based metrics. Therefore, geographic information is presented only for revenue.

Q1 Fiscal 2025 Form 10-Q27

A summary of the segment profit or loss, including significant segment expenses is as follows:Three Months Ended March 31,(In thousands)20252024Total revenue37